Deciphex Finalise 2.3m Equity Fundraising to Accelerate Commercialisation and Research Programs
Deciphex an Irish based technology player, applying AI in pathology, has announced the conclusion of a €2.3m equity funding and convertible debt conversion event which will empower the company to accelerate its research and development in Artificial Intelligence and ramp up market entry in preclincial/toxicologic digital pathology.
Read Full Article from HBAN
Date: April 25, 2019
Provided By: https://www.hban.org/_shared/news/RSSNewsPage.aspx?Id=9